What Is Photobiomodulation?
Photobiomodulation is the process by which red and near infrared light influences cell behavior. In low level light therapy, often abbreviated LLLT, these wavelengths are absorbed by structures in the mitochondria, which can increase ATP production, enhance cell signaling and growth factor release, and reduce oxidative stress.
Over the past several years, low level light therapy has moved from specialized clinical settings into the consumer space, with many devices marketed directly to the public. This rapid growth makes it especially important to understand the actual clinical applications of low level light therapy and the strength of the evidence behind them.
Where Does The Evidence Look Strongest?
This review examined clinical studies using LLLT for several dermatologic and aesthetic concerns, including:
- Skin rejuvenation, such as facial wrinkles and uneven pigmentation
- Acne vulgaris
- Wound healing
- Body contouring
- Androgenic alopecia, also known as pattern hair loss
Overall, the authors found a reasonable body of clinical trial data suggesting that low energy red and near infrared light can be a safe and effective option for skin rejuvenation, improving acne, supporting hair growth in androgenic alopecia, and especially for body contouring.
Gaps And Questions In The Current Research
At the same time, the review highlights important limitations. Many of the available studies include relatively small numbers of patients, methodological weaknesses, or industry sponsorship. These factors make it harder to draw firm, generalizable conclusions.
There is also an open question about how different light sources compare. High quality studies often use laser based systems, while many widely available devices use light emitting diodes. It is not yet clear whether LED based tools consistently produce effects that match those seen with lasers in terms of magnitude and reliability.
Looking Ahead: Turning Hype Into Evidence
The authors conclude that low level light therapy and photobiomodulation are not likely to disappear. The technology is widely available, non invasive and generally well tolerated. However, its commercial success has moved faster than the rigorous, independent trials needed to fully validate its therapeutic potential.
The next step is clear. Well designed, adequately powered clinical studies, free of commercial bias, will be essential to defining when and how low level light therapy should be used in medical and aesthetic care. With stronger evidence, clinicians and patients alike will be better equipped to make informed decisions about this rapidly expanding modality.
Check out the full article here: https://pubmed.ncbi.nlm.nih.gov/33471046/
